Ulrika Yngve

The Drug discovery and development platform has the mission to turn academic projects into innovations. With the capabilities to design and synthesize drug-like compounds, the medicinal chemistry units take the project from a lead generation strategy to a compound suitable for a proof-of-concept in your selected animal model.

In addition, we are implementing the use of DNA encoded libraries as a way to identify novel starting points in our drug discovery projects. This project is lead by Johan Wannberg. During 2024, Nathan Poongavanam joined the group as an expert in machine learning in drug discovery. 

Group Members

Johanna Larsson
Vasanthanathan (Nathan) Poongavanam
Johan Wannberg